Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982269964> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W1982269964 endingPage "762" @default.
- W1982269964 startingPage "751" @default.
- W1982269964 abstract "Desloratadine is a new, selective, H(1)-receptor antagonist that also has anti-inflammatory activity. In vitro studies have shown that desloratadine inhibits the release or generation of multiple inflammatory mediators, including IL-4, IL-6, IL-8, IL-13, PGD(2), leukotriene C(4), tryptase, histamine, and the TNF-alpha-induced chemokine RANTES. Desloratadine also inhibits the induction of cell adhesion molecules, plateletactivating factor-induced eosinophil chemotaxis, TNF-alpha-induced eosinophil adhesion, and spontaneous and phorbol myristate acetate-induced superoxide generation in vitro. In animals desloratadine had no effect on the central nervous, cardiovascular, renal, or gastrointestinal systems. Desloratadine is rapidly absorbed, has dose-proportional pharmacokinetics, and has a half-life of 27 hours. The absorption of desloratadine is not affected by food, and the metabolism and elimination are not significantly affected by the subject's age, race, or sex. There are no clinically relevant interactions between desloratadine and erythromycin, ketoconazole, or grapefruit juice. Desloratadine is not a significant substrate of the P-glycoprotein transport system. Once daily administration of desloratadine rapidly reduces the nasal and nonnasal symptoms of seasonal allergic rhinitis, including congestion. In patients with seasonal allergic rhinitis and concomitant asthma, desloratadine treatment was also associated with significant reductions in total asthma symptom score and use of inhaled beta(2)-agonists. Use of desloratadine in patients with chronic idiopathic urticaria was associated with significant reductions in pruritus, number of hives, size of the largest hive, and interference with sleep and daily activities. Clinical experience in over 2300 patients has shown that the adverse event profile of desloratadine is similar to that of placebo; desloratadine has no clinically relevant effects on electrocardiographic parameters, does not impair wakefulness or psychomotor performance, and does not exacerbate the psychomotor impairment associated with alcohol use." @default.
- W1982269964 created "2016-06-24" @default.
- W1982269964 creator A5048379219 @default.
- W1982269964 creator A5088842944 @default.
- W1982269964 date "2001-04-01" @default.
- W1982269964 modified "2023-09-26" @default.
- W1982269964 title "Desloratadine: A new, nonsedating, oral antihistamine" @default.
- W1982269964 cites W1588576723 @default.
- W1982269964 cites W1974492923 @default.
- W1982269964 cites W1976601877 @default.
- W1982269964 cites W1983591607 @default.
- W1982269964 cites W1990461414 @default.
- W1982269964 cites W2017219757 @default.
- W1982269964 cites W2042612784 @default.
- W1982269964 cites W2057998083 @default.
- W1982269964 cites W2061564002 @default.
- W1982269964 cites W2068797688 @default.
- W1982269964 cites W2080515725 @default.
- W1982269964 cites W2083666610 @default.
- W1982269964 cites W2087691943 @default.
- W1982269964 cites W2099112057 @default.
- W1982269964 cites W2126310184 @default.
- W1982269964 cites W2127645257 @default.
- W1982269964 cites W2150391039 @default.
- W1982269964 cites W2462904491 @default.
- W1982269964 cites W4255812905 @default.
- W1982269964 doi "https://doi.org/10.1067/mai.2001.114239" @default.
- W1982269964 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11295678" @default.
- W1982269964 hasPublicationYear "2001" @default.
- W1982269964 type Work @default.
- W1982269964 sameAs 1982269964 @default.
- W1982269964 citedByCount "143" @default.
- W1982269964 countsByYear W19822699642012 @default.
- W1982269964 countsByYear W19822699642013 @default.
- W1982269964 countsByYear W19822699642014 @default.
- W1982269964 countsByYear W19822699642015 @default.
- W1982269964 countsByYear W19822699642016 @default.
- W1982269964 countsByYear W19822699642017 @default.
- W1982269964 countsByYear W19822699642018 @default.
- W1982269964 countsByYear W19822699642019 @default.
- W1982269964 countsByYear W19822699642020 @default.
- W1982269964 countsByYear W19822699642021 @default.
- W1982269964 countsByYear W19822699642022 @default.
- W1982269964 countsByYear W19822699642023 @default.
- W1982269964 crossrefType "journal-article" @default.
- W1982269964 hasAuthorship W1982269964A5048379219 @default.
- W1982269964 hasAuthorship W1982269964A5088842944 @default.
- W1982269964 hasConcept C2776880894 @default.
- W1982269964 hasConcept C2780734495 @default.
- W1982269964 hasConcept C2781025919 @default.
- W1982269964 hasConcept C71924100 @default.
- W1982269964 hasConcept C98274493 @default.
- W1982269964 hasConceptScore W1982269964C2776880894 @default.
- W1982269964 hasConceptScore W1982269964C2780734495 @default.
- W1982269964 hasConceptScore W1982269964C2781025919 @default.
- W1982269964 hasConceptScore W1982269964C71924100 @default.
- W1982269964 hasConceptScore W1982269964C98274493 @default.
- W1982269964 hasIssue "4" @default.
- W1982269964 hasLocation W19822699641 @default.
- W1982269964 hasLocation W19822699642 @default.
- W1982269964 hasOpenAccess W1982269964 @default.
- W1982269964 hasPrimaryLocation W19822699641 @default.
- W1982269964 hasRelatedWork W161667300 @default.
- W1982269964 hasRelatedWork W2016523948 @default.
- W1982269964 hasRelatedWork W2134291550 @default.
- W1982269964 hasRelatedWork W2162155539 @default.
- W1982269964 hasRelatedWork W229686410 @default.
- W1982269964 hasRelatedWork W2356823892 @default.
- W1982269964 hasRelatedWork W2367108821 @default.
- W1982269964 hasRelatedWork W3126372117 @default.
- W1982269964 hasRelatedWork W4224930249 @default.
- W1982269964 hasRelatedWork W99420955 @default.
- W1982269964 hasVolume "107" @default.
- W1982269964 isParatext "false" @default.
- W1982269964 isRetracted "false" @default.
- W1982269964 magId "1982269964" @default.
- W1982269964 workType "article" @default.